Momenta Pharmaceuticals
MNTA
#2337
Rank
ยฃ4.83 B
Marketcap
ยฃ40.63
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Momenta Pharmaceuticals (MNTA)

Revenue in 2020 (TTM): ยฃ23.99 Million

According to Momenta Pharmaceuticals's latest financial reports the company's current revenue is ยฃ23.27 Million. In 2019 the company made a revenue of ยฃ18.47 Million a decrease over the revenue in the year 2018 that were of ยฃ58.51 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Momenta Pharmaceuticals from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)ยฃ23.99 M29.86%
2019ยฃ18.47 M-68.42%
2018ยฃ58.51 M-45.57%
2017ยฃ0.10 B26.7%
2016ยฃ84.85 M22.28%
2015ยฃ69.39 M71.58%
2014ยฃ40.44 M47.33%
2013ยฃ27.45 M-44.52%
2012ยฃ49.48 M-77.42%
2011ยฃ0.21 B142.41%
2010ยฃ90.39 M476.68%
2009ยฃ15.67 M38.97%
2008ยฃ11.27 M-32.42%
2007ยฃ16.68 M31.7%
2006ยฃ12.67 M13.06%
2005ยฃ11.2 M84.86%
2004ยฃ6.06 M